Anticorps Recombinant de lapin anti-TLR3/CD283

TLR3/CD283 Recombinant Antibody for FC (Intra)

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC (Intra)

Conjugaison

Non conjugué

CloneNo.

230445G9

N° de cat : 98016-2-RR

Synonymes

TLR3, Toll-like receptor 3, toll like receptor 3, CD283, 230445G9



Applications testées

Résultats positifs en FC (Intra)human monocyte-derived immature dendritic cells

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98016-2-RR cible TLR3/CD283 dans les applications de FC (Intra) et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène TLR3/CD283 Protéine recombinante Ag34044
Nom complet toll-like receptor 3
Masse moléculaire calculée 904 aa, 104 kDa
Numéro d’acquisition GenBankBC094737
Symbole du gène TLR3
Identification du gène (NCBI) 7098
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2-8°C. Stable for one year after shipment.

Informations générales

TLR3 belongs to the Toll-like receptor family which is important in the innate immune response to pathogens. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. TLR3 is a nucleotide-sensing TLR that is activated by double-stranded RNA. Upon recognition of dsRNA, TLR3 transmits signals via the adaptor protein TICAM-1/TRIF, leading to the induction of type I IFN, cytokine/chemokine production, and dendritic cell (DC) maturation (PMID: 18262679).

Protocole

Product Specific Protocols
FC protocol for TLR3/CD283 antibody 98016-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}